AI Engines For more Details: Perplexity Kagi Labs You
Neurological Disorders: Glutamate is the primary excitatory neurotransmitter in the central nervous system and plays a crucial role in neuronal communication. However, excessive glutamate signaling can lead to excitotoxicity, which is implicated in the pathogenesis of various neurological disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and stroke. Excitotoxicity occurs when excessive glutamate stimulates receptors on neurons, leading to neuronal damage and cell death.
Migraine: Glutamate has been implicated in the pathophysiology of migraine headaches. Excessive release of glutamate and abnormal glutamate receptor activation may contribute to the initiation and propagation of migraine attacks. Medications that target glutamate receptors or modulate glutamate levels may be used in the treatment of migraines.
Neuropathic Pain: Glutamate signaling plays a role in the development and maintenance of neuropathic pain, which is caused by damage or dysfunction of the nervous system. Aberrant glutamate release and activation of glutamate receptors in the spinal cord and brain contribute to the hypersensitivity to pain experienced in neuropathic conditions such as diabetic neuropathy, postherpetic neuralgia, and neuropathic pain following nerve injury.
Epilepsy: Glutamate-mediated excitatory neurotransmission is involved in the generation and propagation of epileptic seizures. Abnormalities in glutamate signaling, such as excessive glutamate release or impaired glutamate reuptake, can lead to hyperexcitability of neurons and seizure activity. Antiepileptic drugs that target glutamate receptors or modulate glutamate release are used in the treatment of epilepsy.
Neurodegenerative Diseases: Dysregulation of glutamate homeostasis and excitotoxicity have been implicated in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Excessive glutamate signaling contributes to neuronal damage and cell death in these conditions. Therapeutic strategies aimed at reducing glutamate excitotoxicity are being investigated as potential treatments for neurodegenerative diseases.
Psychiatric Disorders: Glutamate dysregulation has been implicated in various psychiatric disorders, including schizophrenia, depression, and anxiety disorders. Abnormalities in glutamate neurotransmission and glutamate receptor function may contribute to the pathophysiology of these conditions. Medications that modulate glutamate signaling are being explored as potential treatments for psychiatric disorders.
Metabolic Disorders: Glutamate also plays a role in energy metabolism and is involved in the synthesis of glutathione, a potent antioxidant. Dysregulation of glutamate metabolism has been implicated in metabolic disorders such as obesity, diabetes, and metabolic syndrome. Alterations in glutamate signaling may affect energy balance, insulin sensitivity, and oxidative stress in metabolic tissues.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Increases |
order | Rhodospirillales | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Bifidobacterium adolescentis | Increases |
species | Bifidobacterium animalis | Increases |
species | Bifidobacterium bifidum | Increases |
species | Bifidobacterium breve | Increases |
species | Bifidobacterium catenulatum | Increases |
species | Bifidobacterium longum | Increases |
species | Bifidobacterium pseudocatenulatum | Increases |
species | Bifidobacterium pseudolongum | Increases |
species | Lactobacillus acidophilus | Increases |
species | Lactobacillus crispatus | Increases |
species | Lactobacillus gasseri | Increases |
species | Lactobacillus helveticus | Increases |
species | Lactobacillus jensenii | Increases |
species | Lactobacillus johnsonii | Increases |
species | Lactobacillus kefiranofaciens | Increases |
species | Lactococcus cremoris | Increases |
species | Lactococcus lactis | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Terrabacteria group | clade | Increases |
0 | 1 | Desulfuribacillia | class | Decreases |
0 | 1 | Dethiobacteria | class | Decreases |
0 | 1 | Erysipelotrichia | class | Decreases |
0 | 1 | Limnochordia | class | Decreases |
0 | 1 | Negativicutes | class | Decreases |
0 | 1 | Thermolithobacteria | class | Decreases |
0 | 1 | Tissierellia | class | Decreases |
0 | 2 | Bacilli | class | Increases |
1 | 2 | Clostridia | class | Increases |
0 | 1 | Acidimicrobiia | class | Increases |
0 | 1 | Actinomycetes | class | Increases |
0 | 1 | Coriobacteriia | class | Increases |
0 | 1 | Nitriliruptoria | class | Increases |
0 | 1 | Rubrobacteria | class | Increases |
0 | 1 | Thermoleophilia | class | Increases |
1 | 0 | Acidaminococcaceae | family | Decreases |
0 | 1 | Acutalibacteraceae | family | Decreases |
0 | 1 | Bianqueaceae | family | Decreases |
0 | 1 | Butyricicoccaceae | family | Decreases |
0 | 1 | Caldicoprobacteraceae | family | Decreases |
0 | 1 | Cellulosilyticaceae | family | Decreases |
0 | 1 | Christensenellaceae | family | Decreases |
0 | 1 | Clostridiaceae | family | Decreases |
0 | 1 | Defluviitaleaceae | family | Decreases |
0 | 1 | Desulfallaceae | family | Decreases |
0 | 1 | Desulfitobacteriaceae | family | Decreases |
0 | 1 | Desulfotomaculaceae | family | Decreases |
0 | 1 | Desulfurisporaceae | family | Decreases |
0 | 1 | Eubacteriaceae | family | Decreases |
0 | 1 | Feifaniaceae | family | Decreases |
0 | 1 | Gracilibacteraceae | family | Decreases |
0 | 1 | Heliobacteriaceae | family | Decreases |
0 | 1 | Lachnospiraceae | family | Decreases |
0 | 1 | Maliibacteriaceae | family | Decreases |
0 | 1 | Oscillospiraceae | family | Decreases |
0 | 1 | Peptococcaceae | family | Decreases |
0 | 1 | Peptostreptococcaceae | family | Decreases |
0 | 1 | Proteinivoraceae | family | Decreases |
0 | 1 | Pumilibacteraceae | family | Decreases |
0 | 1 | Symbiobacteriaceae | family | Decreases |
0 | 1 | Syntrophomonadaceae | family | Decreases |
0 | 1 | Thermincolaceae | family | Decreases |
0 | 1 | Vallitaleaceae | family | Decreases |
0 | 1 | Yeguiaceae | family | Decreases |
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 2 | Bifidobacteriaceae | family | Increases |
0 | 1 | Selenomonadaceae | family | Increases |
0 | 1 | Odoribacteraceae | family | Increases |
0 | 1 | Aerococcaceae | family | Increases |
0 | 1 | Carnobacteriaceae | family | Increases |
0 | 1 | Enterococcaceae | family | Increases |
0 | 2 | Streptococcaceae | family | Increases |
1 | 0 | Prevotellaceae | family | Increases |
0 | 3 | Lactobacillaceae | family | Increases |
1 | 0 | Acidaminococcus | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Phascolarctobacterium | genus | Decreases |
0 | 1 | Succiniclasticum | genus | Decreases |
0 | 1 | Succinispira | genus | Decreases |
2 | 0 | Bifidobacterium | genus | Increases |
0 | 1 | Alloprevotella | genus | Increases |
0 | 1 | Hallella | genus | Increases |
0 | 1 | Hoylesella | genus | Increases |
0 | 1 | Leyella | genus | Increases |
0 | 1 | Marseilla | genus | Increases |
0 | 1 | Massiliprevotella | genus | Increases |
0 | 1 | Metaprevotella | genus | Increases |
0 | 1 | Paraprevotella | genus | Increases |
0 | 1 | Prevotella | genus | Increases |
0 | 1 | Prevotellamassilia | genus | Increases |
0 | 1 | Pseudoprevotella | genus | Increases |
0 | 1 | Segatella | genus | Increases |
0 | 1 | Brevibacterium | genus | Increases |
0 | 1 | Campylobacter | genus | Increases |
0 | 1 | Corynebacterium | genus | Increases |
1 | 0 | Lactococcus | genus | Increases |
2 | 0 | Lactobacillus | genus | Increases |
0 | 1 | Bacillota incertae sedis | no rank | Decreases |
0 | 1 | Bacillota sensu stricto incertae sedis | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | Eubacteriales incertae sedis | no rank | Decreases |
0 | 1 | unclassified Acidaminococcaceae | no rank | Decreases |
0 | 1 | unclassified Acidaminococcus | no rank | Decreases |
0 | 1 | unclassified Bacillota | no rank | Decreases |
0 | 1 | unclassified Eubacteriales | no rank | Decreases |
0 | 2 | environmental samples | no rank | Increases |
0 | 2 | unclassified Bifidobacterium | no rank | Increases |
0 | 1 | Clostridia incertae sedis | no rank | Increases |
0 | 1 | environmental samples | no rank | Increases |
0 | 1 | environmental samples | no rank | Increases |
0 | 1 | environmental samples | no rank | Increases |
0 | 1 | Lactobacillales incertae sedis | no rank | Increases |
0 | 1 | unclassified Actinomycetota | no rank | Increases |
0 | 1 | unclassified Clostridia | no rank | Increases |
0 | 1 | unclassified Lactococcus | no rank | Increases |
0 | 1 | unclassified Prevotellaceae | no rank | Increases |
0 | 2 | environmental samples | no rank | Increases |
0 | 2 | unclassified Lactobacillus | no rank | Increases |
1 | 1 | Eubacteriales | order | Decreases |
0 | 1 | Acidaminococcales | order | Decreases |
0 | 1 | Rhodospirillales | order | Decreases |
0 | 1 | Spirochaetales | order | Decreases |
0 | 1 | Caldicellulosiruptorales | order | Increases |
0 | 1 | Christensenellales | order | Increases |
0 | 1 | Halanaerobiales | order | Increases |
0 | 1 | Koleobacterales | order | Increases |
0 | 1 | Lachnospirales | order | Increases |
0 | 1 | Monoglobales | order | Increases |
0 | 1 | Moorellales | order | Increases |
0 | 1 | Natranaerobiales | order | Increases |
0 | 1 | Peptostreptococcales | order | Increases |
0 | 1 | Saccharofermentanales | order | Increases |
0 | 1 | Thermoanaerobacterales | order | Increases |
0 | 1 | Thermosediminibacterales | order | Increases |
0 | 1 | Bacteroidales | order | Increases |
1 | 0 | Lactobacillales | order | Increases |
1 | 1 | Bacillota | phylum | Decreases |
0 | 1 | Spirochaetota | phylum | Decreases |
1 | 0 | Actinomycetota | phylum | Increases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
0 | 1 | Acidaminococcus sp. BV3L6 | species | Decreases |
0 | 1 | Acidaminococcus sp. HPA0509 | species | Decreases |
0 | 1 | Acidaminococcus fermentans | species | Decreases |
0 | 1 | Acidaminococcus intestini | species | Decreases |
0 | 1 | Acidaminococcus massiliensis | species | Decreases |
0 | 1 | Acidaminococcus sp. | species | Decreases |
0 | 1 | Acidaminococcus sp. D21 | species | Decreases |
0 | 1 | Acidaminococcus timonensis | species | Decreases |
0 | 2 | Bifidobacterium actinocoloniiforme | species | Increases |
0 | 2 | Bifidobacterium adolescentis | species | Increases |
0 | 2 | Bifidobacterium aesculapii | species | Increases |
0 | 2 | Bifidobacterium angulatum | species | Increases |
0 | 2 | Bifidobacterium animalis | species | Increases |
0 | 2 | Bifidobacterium asteroides | species | Increases |
0 | 2 | Bifidobacterium avesanii | species | Increases |
0 | 2 | Bifidobacterium biavatii | species | Increases |
0 | 2 | Bifidobacterium bifidum | species | Increases |
0 | 2 | Bifidobacterium bohemicum | species | Increases |
0 | 2 | Bifidobacterium bombi | species | Increases |
0 | 2 | Bifidobacterium boum | species | Increases |
0 | 2 | Bifidobacterium breve | species | Increases |
0 | 2 | Bifidobacterium callitrichidarum | species | Increases |
0 | 2 | Bifidobacterium callitrichos | species | Increases |
0 | 2 | Bifidobacterium catenulatum | species | Increases |
0 | 2 | Bifidobacterium choerinum | species | Increases |
0 | 2 | Bifidobacterium commune | species | Increases |
0 | 2 | Bifidobacterium coryneforme | species | Increases |
0 | 2 | Bifidobacterium cuniculi | species | Increases |
0 | 2 | Bifidobacterium dentium | species | Increases |
0 | 2 | Bifidobacterium eulemuris | species | Increases |
0 | 2 | Bifidobacterium faecale | species | Increases |
0 | 2 | Bifidobacterium gallicum | species | Increases |
0 | 2 | Bifidobacterium imperatoris | species | Increases |
0 | 2 | Bifidobacterium indicum | species | Increases |
0 | 2 | Bifidobacterium lemurum | species | Increases |
0 | 2 | Bifidobacterium longum | species | Increases |
0 | 2 | Bifidobacterium magnum | species | Increases |
0 | 2 | Bifidobacterium merycicum | species | Increases |
0 | 2 | Bifidobacterium minimum | species | Increases |
0 | 2 | Bifidobacterium mongoliense | species | Increases |
0 | 2 | Bifidobacterium moukalabense | species | Increases |
0 | 2 | Bifidobacterium myosotis | species | Increases |
0 | 2 | Bifidobacterium porcinum | species | Increases |
0 | 2 | Bifidobacterium pseudocatenulatum | species | Increases |
0 | 2 | Bifidobacterium pseudolongum | species | Increases |
0 | 2 | Bifidobacterium psychraerophilum | species | Increases |
0 | 2 | Bifidobacterium pullorum | species | Increases |
0 | 2 | Bifidobacterium reuteri | species | Increases |
0 | 2 | Bifidobacterium ruminantium | species | Increases |
0 | 2 | Bifidobacterium saguini | species | Increases |
0 | 2 | Bifidobacterium scardovii | species | Increases |
0 | 2 | Bifidobacterium simiae | species | Increases |
0 | 2 | Bifidobacterium stellenboschense | species | Increases |
0 | 2 | Bifidobacterium subtile | species | Increases |
0 | 2 | Bifidobacterium thermacidophilum | species | Increases |
0 | 2 | Bifidobacterium thermophilum | species | Increases |
0 | 2 | Bifidobacterium tissieri | species | Increases |
0 | 2 | Bifidobacterium tsurumiense | species | Increases |
0 | 1 | ATCC 15434 | species | Increases |
0 | 1 | Bifidobacterium stercoris | species | Increases |
0 | 1 | Lactobacillus sp. 7_1_47FAA | species | Increases |
0 | 1 | Lactobacillus sp. MYMRS/TEN2 | species | Increases |
0 | 1 | Lactococcus allomyrinae | species | Increases |
0 | 1 | Lactococcus carnosus | species | Increases |
0 | 1 | Lactococcus cremoris | species | Increases |
0 | 1 | Lactococcus formosensis | species | Increases |
0 | 1 | Lactococcus fujiensis | species | Increases |
0 | 1 | Lactococcus garvieae | species | Increases |
0 | 1 | Lactococcus hircilactis | species | Increases |
0 | 1 | Lactococcus lactis | species | Increases |
0 | 1 | Lactococcus laudensis | species | Increases |
0 | 1 | Lactococcus paracarnosus | species | Increases |
0 | 1 | Lactococcus petauri | species | Increases |
0 | 1 | Lactococcus piscium | species | Increases |
0 | 1 | Lactococcus plantarum | species | Increases |
0 | 1 | Lactococcus protaetiae | species | Increases |
0 | 1 | Lactococcus raffinolactis | species | Increases |
0 | 1 | Lactococcus taiwanensis | species | Increases |
0 | 2 | [Lactobacillus] rogosae | species | Increases |
0 | 2 | Lactobacillus acetotolerans | species | Increases |
0 | 2 | Lactobacillus acidophilus | species | Increases |
0 | 2 | Lactobacillus alvei | species | Increases |
0 | 2 | Lactobacillus amylolyticus | species | Increases |
0 | 2 | Lactobacillus amylovorus | species | Increases |
0 | 2 | Lactobacillus animata | species | Increases |
0 | 2 | Lactobacillus apis | species | Increases |
0 | 2 | Lactobacillus bombicola | species | Increases |
0 | 2 | Lactobacillus brevisimilis | species | Increases |
0 | 2 | Lactobacillus crispatus | species | Increases |
0 | 2 | Lactobacillus delbrueckii | species | Increases |
0 | 2 | Lactobacillus equicursoris | species | Increases |
0 | 2 | Lactobacillus faeni | species | Increases |
0 | 2 | Lactobacillus fornicalis | species | Increases |
0 | 2 | Lactobacillus gallinarum | species | Increases |
0 | 2 | Lactobacillus gasseri | species | Increases |
0 | 2 | Lactobacillus gigeriorum | species | Increases |
0 | 2 | Lactobacillus guizhouensis | species | Increases |
0 | 2 | Lactobacillus hamsteri | species | Increases |
0 | 2 | Lactobacillus helsingborgensis | species | Increases |
0 | 2 | Lactobacillus helveticus | species | Increases |
0 | 2 | Lactobacillus hominis | species | Increases |
0 | 2 | Lactobacillus iners | species | Increases |
0 | 2 | Lactobacillus intermedius | species | Increases |
0 | 2 | Lactobacillus intestinalis | species | Increases |
0 | 2 | Lactobacillus japonicus | species | Increases |
0 | 2 | Lactobacillus jensenii | species | Increases |
0 | 2 | Lactobacillus johnsonii | species | Increases |
0 | 2 | Lactobacillus kalixensis | species | Increases |
0 | 2 | Lactobacillus kefiranofaciens | species | Increases |
0 | 2 | Lactobacillus kitasatonis | species | Increases |
0 | 2 | Lactobacillus kullabergensis | species | Increases |
0 | 2 | Lactobacillus leichmannii | species | Increases |
0 | 2 | Lactobacillus letivazi | species | Increases |
0 | 2 | Lactobacillus mulieris | species | Increases |
0 | 2 | Lactobacillus panisapium | species | Increases |
0 | 2 | Lactobacillus paragasseri | species | Increases |
0 | 2 | Lactobacillus pasteurii | species | Increases |
0 | 2 | Lactobacillus psittaci | species | Increases |
0 | 2 | Lactobacillus rodentium | species | Increases |
0 | 2 | Lactobacillus selangorensis | species | Increases |
0 | 2 | Lactobacillus taiwanensis | species | Increases |
0 | 2 | Lactobacillus terrae | species | Increases |
0 | 2 | Lactobacillus ultunensis | species | Increases |
1 | 0 | Brevibacterium avium | species | Increases |
1 | 0 | Campylobacter jejuni | species | Increases |
1 | 0 | Corynebacterium glutamicum | species | Increases |
0 | 2 | Lactobacillus casei group | species group | Increases |
0 | 1 | Campylobacter jejuni subsp. doylei | subspecies | Increases |
0 | 1 | Campylobacter jejuni subsp. jejuni | subspecies | Increases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.2 | -0.2 | |
Acne | 1.6 | 0.5 | 2.2 |
ADHD | 2.2 | 2.1 | 0.05 |
Age-Related Macular Degeneration and Glaucoma | 0.3 | -0.3 | |
Allergic Rhinitis (Hay Fever) | 2.2 | 1.3 | 0.69 |
Allergies | 2.4 | 4 | -0.67 |
Allergy to milk products | 2.5 | 0.9 | 1.78 |
Alopecia (Hair Loss) | 0.3 | 0.7 | -1.33 |
Alzheimer's disease | 3.8 | 3.6 | 0.06 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.9 | 2.3 | -1.56 |
Ankylosing spondylitis | 2.1 | 1.5 | 0.4 |
Anorexia Nervosa | 0.7 | 1.9 | -1.71 |
Asthma | 2.3 | 3.6 | -0.57 |
Atherosclerosis | 0.5 | 1.7 | -2.4 |
Atrial fibrillation | 0.4 | 1.8 | -3.5 |
Autism | 4.9 | 4.5 | 0.09 |
Autoimmune Disease | 1 | 0.8 | 0.25 |
Barrett esophagus cancer | 0.5 | 0.5 | |
benign prostatic hyperplasia | 0.5 | -0.5 | |
Biofilm | 0 | 0 | |
Bipolar Disorder | 0.7 | 1.8 | -1.57 |
Brain Trauma | 2.8 | 0.1 | 27 |
Breast Cancer | 0.5 | 0.2 | 1.5 |
Cancer (General) | 1 | 0.2 | 4 |
Carcinoma | 0.2 | 0.8 | -3 |
Celiac Disease | 2 | 1.6 | 0.25 |
Cerebral Palsy | 0.4 | 0.2 | 1 |
Chronic Fatigue Syndrome | 1.2 | 2.2 | -0.83 |
Chronic Kidney Disease | 1.5 | 0.8 | 0.88 |
Chronic Obstructive Pulmonary Disease (COPD) | 1.1 | 2.6 | -1.36 |
Chronic Urticaria (Hives) | 0.2 | 1.9 | -8.5 |
Coagulation / Micro clot triggering bacteria | 0.8 | 0.3 | 1.67 |
Cognitive Function | 1.7 | 1.1 | 0.55 |
Colorectal Cancer | 3 | 3 | 0 |
Constipation | 1.4 | 1.4 | |
Coronary artery disease | 1.3 | 1.1 | 0.18 |
COVID-19 | 3.7 | 5.8 | -0.57 |
Crohn's Disease | 2.8 | 5.8 | -1.07 |
cystic fibrosis | 0.1 | 0.8 | -7 |
d-lactic acidosis (one form of brain fog) | 1.4 | -1.4 | |
deep vein thrombosis | 1 | 0.2 | 4 |
Denture Wearers Oral Shifts | 0.6 | 0.3 | 1 |
Depression | 5.9 | 6.8 | -0.15 |
Dermatomyositis | 0 | 0.5 | 0 |
Eczema | 0.5 | 0.5 | 0 |
Endometriosis | 2 | 2.2 | -0.1 |
Eosinophilic Esophagitis | 0.1 | 0.8 | -7 |
Epilepsy | 2.4 | 2.4 | 0 |
erectile dysfunction | 0.8 | 0.2 | 3 |
Fibromyalgia | 1 | 0.8 | 0.25 |
Functional constipation / chronic idiopathic constipation | 2.6 | 1.7 | 0.53 |
gallstone disease (gsd) | 0.6 | 0.7 | -0.17 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.8 | 0.7 | 0.14 |
Generalized anxiety disorder | 0.9 | 0.6 | 0.5 |
giant cell arteritis | 0.2 | 0.3 | -0.5 |
Glioblastoma | 0.4 | 0.5 | -0.25 |
Gout | 0.8 | 1.6 | -1 |
Graves' disease | 0.9 | 4 | -3.44 |
Gulf War Syndrome | 0.2 | 1.5 | -6.5 |
Halitosis | 0.5 | 0.7 | -0.4 |
Hashimoto's thyroiditis | 1.9 | 1.3 | 0.46 |
Heart Failure | 1.4 | 2.2 | -0.57 |
hemorrhagic stroke | 1.5 | 0.2 | 6.5 |
Hemorrhoidal disease, Hemorrhoids, Piles | 0.2 | 0.2 | 0 |
Hidradenitis Suppurativa | 0.6 | -0.6 | |
High Histamine/low DAO | 0.7 | 0.6 | 0.17 |
hypercholesterolemia (High Cholesterol) | 0.2 | 0.7 | -2.5 |
hyperglycemia | 1.1 | 1.1 | 0 |
Hyperlipidemia (High Blood Fats) | 1.4 | 1 | 0.4 |
hypersomnia | 0.8 | 0.6 | 0.33 |
hypertension (High Blood Pressure | 2.9 | 3 | -0.03 |
Hypothyroidism | 1.2 | 0.9 | 0.33 |
Hypoxia | 0.6 | 1 | -0.67 |
IgA nephropathy (IgAN) | 1.2 | 0.9 | 0.33 |
Inflammatory Bowel Disease | 3.1 | 4.1 | -0.32 |
Insomnia | 1.5 | 3.6 | -1.4 |
Intelligence | 1.1 | 1.1 | |
Intracranial aneurysms | 1 | 0.2 | 4 |
Irritable Bowel Syndrome | 4.2 | 4.4 | -0.05 |
ischemic stroke | 1.4 | 2 | -0.43 |
Juvenile idiopathic arthritis | 0.8 | -0.8 | |
Liver Cirrhosis | 3.9 | 4.2 | -0.08 |
Long COVID | 3.8 | 7.1 | -0.87 |
Low bone mineral density | 1.1 | -1.1 | |
Lung Cancer | 0.1 | 1 | -9 |
Lymphoma | 0.2 | -0.2 | |
Mast Cell Issues / mastitis | 1.9 | 0.2 | 8.5 |
ME/CFS with IBS | 0 | 0 | |
ME/CFS without IBS | 0.2 | 0.2 | |
membranous nephropathy | 0.4 | -0.4 | |
Menopause | 0.8 | 0.5 | 0.6 |
Metabolic Syndrome | 3.5 | 5.8 | -0.66 |
Mood Disorders | 6.5 | 7.9 | -0.22 |
multiple chemical sensitivity [MCS] | 0.3 | 0.6 | -1 |
Multiple Sclerosis | 3.3 | 2.2 | 0.5 |
Multiple system atrophy (MSA) | 1 | 0.8 | 0.25 |
myasthenia gravis | 0.2 | 0.5 | -1.5 |
neuropathic pain | 0.6 | 0.4 | 0.5 |
Neuropathy (all types) | 1.2 | 0.8 | 0.5 |
neuropsychiatric disorders (PANDAS, PANS) | 0.2 | 0.3 | -0.5 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.1 | 3 | -0.43 |
NonCeliac Gluten Sensitivity | 1.5 | 0.8 | 0.88 |
Obesity | 3.5 | 5 | -0.43 |
obsessive-compulsive disorder | 1.2 | 0.7 | 0.71 |
Osteoarthritis | 0.8 | 0.8 | 0 |
Osteoporosis | 1.1 | 1.9 | -0.73 |
pancreatic cancer | 0.2 | 0.6 | -2 |
Parkinson's Disease | 5.3 | 4.1 | 0.29 |
Peanut Allergy | 0.2 | -0.2 | |
Polycystic ovary syndrome | 1.9 | 4.2 | -1.21 |
Postural orthostatic tachycardia syndrome | 0 | 0 | |
Premenstrual dysphoric disorder | 0 | 0 | |
primary biliary cholangitis | 1 | 2.8 | -1.8 |
Primary sclerosing cholangitis | 2 | -2 | |
Psoriasis | 1.1 | 2.2 | -1 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3.9 | 4.5 | -0.15 |
Rosacea | 0.6 | 1.5 | -1.5 |
Schizophrenia | 4 | 4.9 | -0.23 |
scoliosis | 0.5 | 0.5 | |
sensorineural hearing loss | 0.2 | -0.2 | |
Sjögren syndrome | 1.2 | 0.7 | 0.71 |
Sleep Apnea | 1.9 | 0.6 | 2.17 |
Slow gastric motility / Gastroparesis | 0.8 | 0.2 | 3 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | 0.9 | -2 |
Stress / posttraumatic stress disorder | 1.6 | 1.9 | -0.19 |
Systemic Lupus Erythematosus | 3.1 | 3 | 0.03 |
Tic Disorder | 1 | 0.2 | 4 |
Tourette syndrome | 0.8 | 0.4 | 1 |
Type 1 Diabetes | 2.2 | 2.5 | -0.14 |
Type 2 Diabetes | 3.6 | 5.1 | -0.42 |
Ulcerative colitis | 3.3 | 5.9 | -0.79 |
Unhealthy Ageing | 0.5 | 1.3 | -1.6 |
Vitiligo | 0.7 | 0.6 | 0.17 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]